Implantation Site of a Port Delivery System With Ranibizumab: Anterior Segment Optical Coherence Tomography Evaluation.

Ericksen, Connor J; Christensen, Cory A; Berger, Brian; Gune, Shamika; Nielsen, Jared S

Ericksen, Connor J; Christensen, Cory A; Berger, Brian; Gune, Shamika; Nielsen, Jared S.

Afiliação

Ericksen CJ; Vitreoretinal Diseases and Surgery, Wolfe Eye Clinic, West Des Moines, IA, USA.
Christensen CA; Des Moines University, Des Moines, IA, USA.
Berger B; Austin Clinical Research, Austin, TX, USA.
Gune S; Genentech Inc, South San Francisco, CA, USA.
Nielsen JS; Vitreoretinal Diseases and Surgery, Wolfe Eye Clinic, West Des Moines, IA, USA.

J Vitreoretin Dis ; 6(5): 347-350, 2022.

Article em En | MEDLINE | ID: mdl-37006905

Palavras-chave

anterior segment OCT; antivascular endothelial growth factor therapy; conjunctival erosion; conjunctival retraction; implant; neovascular age-related macular degeneration; port delivery system; ranibizumab; sustained release

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Qualitative_research Idioma: En Revista: J Vitreoretin Dis Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google